Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Infliximab attenuates joint de...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Export Ready —
Infliximab attenuates joint destruction in early RA patients with ultrasonographic markers of poor prognosis.
Bibliographic Details
Main Authors:
Taylor, P
,
Steuer, A
,
Gruber, J
,
McClinton, C
,
Cosgrove, D
,
Blomley, M
,
Wagner, C
,
Marsters, P
,
Maini, R
Format:
Conference item
Published:
2002
Holdings
Description
Similar Items
Staff View
Similar Items
JOINT DESTRUCTION IS ATTENUATED BY INFLIXIMAB IN EARLY RA PATIENTS WITH ULTRASONOGRAPHIC MARKERS OF POOR PROGNOSIS
by: Taylor, P, et al.
Published: (2003)
Ultrasonographic and radiographic evidence of attenuated joint destruction in early RA patients treated with infliximab
by: Taylor, P, et al.
Published: (2003)
Ultrasonographic evidence of attenuated joint destruction within 18 weeks in early RA patients treated with infliximab.
by: Taylor, P, et al.
Published: (2003)
Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis.
by: Taylor, P, et al.
Published: (2004)
Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiological evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis.
by: Taylor, P, et al.
Published: (2003)